Navigation Links
Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Date:1/8/2008

tment period. The primary efficacy endpoint of the trial will be the increase from baseline in spontaneous bowel movements per week (SBMs per week). Additional endpoints include monitoring of other symptoms of OBD, which will include the Patient Assessment of Constipation Symptoms (PAC-SYM) outcomes tool, and other quality of life measures. Maintenance of opioid analgesic effect will be assessed by measuring changes from baseline in mean daily opioid requirements and daily pain scores. Safety and tolerability will be assessed and pharmacokinetics of the drug will be evaluated. The trial will be conducted in approximately 50 centers in North America and Europe.

About NKTR-118

NKTR-118 is an oral drug that combines Nektar's advanced small molecule PEGylation technology platform with naloxol, a derivative of the opioid-antagonist drug, naloxone. In preclinical studies, Nektar's PEGylation technology has been shown to reduce penetration of drugs across the blood-brain barrier, an important potential advance for NKTR-118 and possibly many other small molecule therapies.

The peripheral opioid antagonist NKTR-118 targets opioid receptors within the enteric nervous system, which mediate OBD, a symptom complex resulting from opioid use that encompasses constipation, bloating, abdominal cramping, and gastroesophageal reflux. Constipation is the hallmark of this syndrome, and is generally its most prominent component. Currently, there are no specific drugs approved or specifically indicated to treat OBD or OIC. NKTR-118 has been studied in two Phase 1 trials evaluating the safety, tolerability and pharmacokinetics of single and repeated dose administration of the drug.

In a proof-of-principle Phase 1 trial, single oral doses of NKTR-118 antagonized morphine-induced delay in gastrointestinal transit time demonstrating the potential of the drug to relieve constipation caused by opioid treatment. This effect was seen to increase in a dose-dependent fas
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
4. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
8. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
9. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
10. Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
11. Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s ... a targeting guide with accompanying instrumentation to place and ... adjunct to the soft tissue (e.g. ligament) repair or ... tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... 14, 2014   NuAire , a manufacturer of ergonomically designed ... Hitachi Koki of Japan to sell ... America . NuAire will utilize its network of sales professionals ... Canada to offer assistance in application use, product benefits ...
(Date:1/14/2014)...   Oligomerix, Inc. , a privately held company pioneering ... (AD) and related neurodegenerative disorders, announced today the relocation ... as of January 15, 2014 and expanded ... Medical College. Oligomerix, which is focused on ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... 2010 As families gather for the holidays ... and their caregivers to make family health part ... to know one,s family health history, it,s also ... care and best ways to manage heath care ...
... Reportlinker.com announces that a new market research ... Global Medical Oxygen Systems Industry ... analyzes the worldwide markets for Medical Oxygen Systems ... Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, ...
Cached Medicine Technology:CVS/pharmacy Helps Seniors Evaluate Medicare Part D Options and Identify Potential Ways to Save on Prescription Drugs in 2011 2Reportlinker Adds Global Medical Oxygen Systems Industry 2Reportlinker Adds Global Medical Oxygen Systems Industry 3Reportlinker Adds Global Medical Oxygen Systems Industry 4Reportlinker Adds Global Medical Oxygen Systems Industry 5Reportlinker Adds Global Medical Oxygen Systems Industry 6Reportlinker Adds Global Medical Oxygen Systems Industry 7Reportlinker Adds Global Medical Oxygen Systems Industry 8Reportlinker Adds Global Medical Oxygen Systems Industry 9Reportlinker Adds Global Medical Oxygen Systems Industry 10Reportlinker Adds Global Medical Oxygen Systems Industry 11Reportlinker Adds Global Medical Oxygen Systems Industry 12Reportlinker Adds Global Medical Oxygen Systems Industry 13Reportlinker Adds Global Medical Oxygen Systems Industry 14Reportlinker Adds Global Medical Oxygen Systems Industry 15Reportlinker Adds Global Medical Oxygen Systems Industry 16
(Date:4/18/2014)... Calif. (April 18, 2014) ― A new study in ... weekly patterns in health-related Google searches reveals a recurring ... strategies. , Investigators from San Diego State ... the Monday Campaigns, analyzed "healthy" Google searches (searches that ... "healthy diet") originating in the U.S. from 2005 to ...
(Date:4/17/2014)... of chronic inflammation in non-cancerous prostate tissue may have ... than those with no inflammation, according to results of ... Hopkins Kimmel Cancer Center. , The link between persistent ... so-called high-grade prostate cancer those with a Gleason ... of the most aggressive and rapidly growing prostate cancers. ...
(Date:4/17/2014)... in PLOS Pathogens , children who live in ... mount an immune response to infection with malaria parasites ... high fever and illness and partially control the growth ... help researchers develop future interventions that prevent or mitigate ... year, approximately 200 million cases of malaria occur worldwide, ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... , ST. PAUL, Minn., Dec. 10 /PRNewswire-USNewswire/ ... Centers, will host their 6th annual blood drive event with ... drive, taking place at the St. Paul Donor Center (I-94 ... other players and cheerleaders scheduled to arrive around 2 PM. ...
... , MT. CLEMENS, Mich., Dec. 10 Four new ... Health Department. Everyone over 6 months of age can receive the ... take place Dec. 14, 17, 19 and 21 at Bethesda Christian ... at 14000 Metropolitan Parkway, on the southeast corner of Schoenherr. The ...
... , Television, movie and music personalities urge people ... WASHINGTON, Dec. 10 A group of celebrities ... new American Red Cross holiday giving campaign and give a gift ... http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , Celebrity supporters of the Red Cross ...
... , ARLINGTON, Va., Dec. ... depression , but are highly aware of the risks of ... National Alliance on Mental Illness (NAMI). , See full ... includes resources for people of diverse communities. , Though depression is ...
... providers face shutdowns, layoffs due to State,s inability to pay ... , AARP, advocates call on State to adopt urgent ... seniors to nursing homes , CHICAGO, Dec. 10 ... the consequences that Illinois, social service agencies face due to ...
... Dec. 10 Breast cancer survivors and advocates ... the Cure® signaled their alarm today at the recently announced ... would effectively shut the doors to breast cancer screening services ... six months of 2010. , Citing budgetary concerns, ...
Cached Medicine News:Health News:Minnesota Vikings Team With Memorial Blood Centers Again for Annual Blood Drive 2Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2Health News:Entertainment Celebrities Support Red Cross Holiday Giving Campaign 2Health News:Entertainment Celebrities Support Red Cross Holiday Giving Campaign 3Health News:Depression Survey: Implications for Diverse Communities 2Health News:State $200 Million Behind in Payments to Agencies Providing Care to Thousands of Older Illinoisans 2Health News:California Breast Cancer Survivors and Advocates Call on State to Nix Screening Cuts 2Health News:California Breast Cancer Survivors and Advocates Call on State to Nix Screening Cuts 3
Cholesterol/HDL with 200 tests....
Intended for the in vitro precipitation of very low density and low density lipoproteins in serum or plasma. Single vial, dry powder precipitating reagent. Total cholesterol reagent not included....
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
... the quantitative determination of ... vials, dry powder reagents. ... NADPH to eliminate interferences ... Reaction: Enzymatic, endpoint. Wavelength: ...
Medicine Products: